Health
Bahrain Approves China’s Sinopharm Covid-19 Vaccine – BloombergQuint
Bahrain Approves China’s Sinopharm Covid-19 Vaccine
(Bloomberg) — Bahrain approved the registration of the Sinopharm Group Co Ltd. vaccine against the coronavirus, about a week after the United Arab Emirates registered the Chinese-made vaccine.
Results from Phase III clinical trials showed an 86% efficacy rate, a 99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of Covid-19, the National Health Regulatory Authority said in a statement Sunday. Bahrains findings are based on data from more…
-
General16 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business23 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
General24 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips
-
General7 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay